BEIJING, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ — Lotus
Pharmaceuticals, Inc. (OTC Bulletin Board:
LTUS) (“Lotus” or the “Company”), a fast-growing, profitable
developer, manufacturer and seller of medicine and drugs in the
People’s Republic of China (“PRC”), announced today that it will
hold a conference call to discuss financial results for the third
quarter ended September 30, 2010. The conference call is scheduled
for November 11, 2010 at 1:00 p.m. Eastern time (10:00 a.m.
To participate in the call, please dial (877) 941-1430, or (480)
629-9667 for international calls, approximately 10 minutes prior to
the scheduled start time. Interested parties can also listen via a
live Internet webcast, which can be found at http://ViaVid.net.
A replay of the call will be available for two weeks from 4:00
p.m. EST on November 11, 2010 until 11:59 p.m. EST on November 25,
2010. The number for the replay is (877) 870-5176, or (858)
858-384-5517 for international calls; the pass code for the replay
About Lotus Pharmaceuticals, Inc. Lotus Pharmaceuticals, Inc.
is a fast-growing, profitable developer and producer of drugs and a
licensed national seller of pharmaceutical items in the People’s
Republic of China (PRC). Lotus operates its business through its
two controlled entities: Liang Fang Pharmaceutical, Ltd. and En Ze
Jia Shi Pharmaceutical, Ltd. Lotus’ current drug development is
focused on the treatment of cerebro-cardiovascular diseases, asthma
and diabetes. Liang Fang sells drugs directly and indirectly
through its national sales channels to hospitals, clinics and drugs
stores in 30 provinces of the PRC.
Information Regarding Forward-Looking StatementsExcept for
historical information contained herein, the statements in this
press release are forward-looking statements that are made